GENINUS Inc. (KOSDAQ:389030)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medical Labs & Research	6.46B	6.97B	10.08B
Medical Labs & Research Growth	-7.35%	-30.90%	-
Total	6.46B	6.97B	10.08B
Total Growth	-7.35%	-30.90%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
South Korea	6.35B	6.64B	9.82B
South Korea Growth	-4.41%	-32.34%	-
Asia	105.15M	32.85M	21.85M
Asia Growth	220.07%	50.38%	-
United States	-	290.97M	242.97M
United States Growth	-	19.75%	-
Total	6.46B	6.97B	10.08B
Total Growth	-7.35%	-30.90%	-

Source: S&P Global Market Intelligence.